Sean P. Nolan Taysha Gene Therapies, Inc. (TSHA) insider trading activity
Sean P. Nolan is Chief Executive Officer of Taysha Gene Therapies, Inc.. Currently has a direct ownership of 1.19 Million shares of TSHA, which is worth approximately $2.19 Million. The most recent transaction as insider was on Jan 02, 2024, when has been sold 1,184,688 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.19M
0%
3M change
101255.38%
12M change
Total Value Held
$2.19 Million
Sean P. Nolan Transaction History
Also insider at
SPN
Sean P. Nolan
Chief Executive Officer
Chicago, IL